These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2792664

  • 1. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C, Heintges T, Rovati L, Strohmeyer G.
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [Abstract] [Full Text] [Related]

  • 2. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Rovati L, Setnikar I.
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [Abstract] [Full Text] [Related]

  • 3. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J, Niederau M, Lüthen R, Niederau C.
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [Abstract] [Full Text] [Related]

  • 4. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E, Ricci R, Biliotti D, Bontempo I, De Medici A, Pallotta N, Torsoli A.
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [Abstract] [Full Text] [Related]

  • 5. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE, Creutzfeldt W, Höcker M, Choudhury AR, Nustede R, Schleser A, Nitsche R, Rovati LC, Schafmayer A, Fölsch UR.
    Digestion; 1990 Jan; 46 Suppl 2():232-9. PubMed ID: 2262057
    [Abstract] [Full Text] [Related]

  • 6. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Bekkering M, Giacovelli G, D'Amato M, Rovati LC.
    Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
    [Abstract] [Full Text] [Related]

  • 7. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA, de Boer SY, Lam WF, Rovati LC, Lamers CB, Masclee AA.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [Abstract] [Full Text] [Related]

  • 8. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C, Schwarzendrube J, Lüthen R, Niederau M, Strohmeyer G, Rovati L.
    Pancreas; 1992 Dec; 7(1):1-10. PubMed ID: 1557335
    [Abstract] [Full Text] [Related]

  • 9. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
    Tsubo K, Arai M, Omachi H, Mitamura K.
    J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
    [Abstract] [Full Text] [Related]

  • 10. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C, Karaus M.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [Abstract] [Full Text] [Related]

  • 11. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Höcker M, Nitsche R, Sostmann H, Rovati LC, Fölsch UR.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [Abstract] [Full Text] [Related]

  • 12. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
    Niederau C, Faber S, Karaus M.
    Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
    [Abstract] [Full Text] [Related]

  • 13. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M, Erlacher U, Schwizer W, Löchner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A.
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [Abstract] [Full Text] [Related]

  • 14. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW, Konturek SJ, Kurek A, Bogdal J, Oleksy J, Rovati L.
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [Abstract] [Full Text] [Related]

  • 15. Role of cholecystokinin in regulation of gastrointestinal motor functions.
    Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, Rovati LC, Stalder GA.
    Lancet; 1989 Jul 01; 2(8653):12-5. PubMed ID: 2567793
    [Abstract] [Full Text] [Related]

  • 16. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
    Fried M, Schwizer W, Beglinger C, Keller U, Jansen JB, Lamers CB.
    Diabetologia; 1991 Oct 01; 34(10):721-6. PubMed ID: 1959704
    [Abstract] [Full Text] [Related]

  • 17. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW.
    J Physiol Pharmacol; 1994 Dec 01; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [Abstract] [Full Text] [Related]

  • 18. Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans.
    Palasciano G, Portincasa P, Belfiore A, Baldassarre G, Albano O.
    Gastroenterology; 1992 Feb 01; 102(2):633-9. PubMed ID: 1732132
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H, Yazaki N, Yomota E, Shikano T, Endo T, Nagasaki M.
    Eur J Pharmacol; 1996 Sep 26; 312(2):227-33. PubMed ID: 8894600
    [Abstract] [Full Text] [Related]

  • 20. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K, Saito T, Saeki M, Ninomiya K, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1997 Oct 26; 47(10):1130-3. PubMed ID: 9368707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.